Clorox (CLX) Tops Q2 EPS by 16c; offers guidance

Clorox (NYSE: CLX) reported Q2 EPS of $1.55, $0.16 better than the analyst estimate of $1.39. Revenue for the quarter came in at $1.69 billion versus the consensus estimate of $1.63 billion.

GUIDANCE:

Clorox sees FY2025 EPS of $6.95-$7.35, versus the consensus of $6.87.

For earnings history and earnings-related data on Clorox (CLX) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• AI/ML Innovations plans $2M private placement on the CSE
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c